Pfizer India has become the first pharmaceutical firm to seek from the DCGI an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain.
New Delhi, Mar 4: As many as 436 people died during clinical trials in the country in 2012, of which only 16 were attributed directly to such experiments.“As per available data, the number of serious
Top News
Latest News
